Regulatory long non-coding RNAs and neuronal disorders

Physiology and Behavior

Volumn 100, Issue 3, 2010, Pages 250-254

  Kohtz, Jhumku D ^a   Berghoff, Emily G ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

GABA; Non coding RNA; Rett syndrome; Transcription

Indexed keywords

4 AMINOBUTYRIC ACID; BC200 RNA; BETA SECRETASE 1; FRAGILE X MENTAL RETARDATION PROTEIN; GLUTAMATE DECARBOXYLASE 67; METHYL CPG BINDING PROTEIN 2; MICRORNA; PIWI INTERACTING RNA; PROTEIN GAD1; RIBOSOME RNA; SMALL INTERFERING RNA; SMALL NUCLEOLAR RNA; SZ 1 RNA; TRANSFER RNA; UNCLASSIFIED DRUG; UNTRANSLATED RNA; REGULATORY RNA SEQUENCE;

ARTICLE; AUTISM; CELL FUNCTION; DNA MODIFICATION; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENE FUNCTION; GENETIC RISK; HUMAN; NERVE CELL PLASTICITY; NEUROPATHY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY RNA SEQUENCE; SCHIZOPHRENIA; TRANSCRIPTION REGULATION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HIPPOCAMPUS; INTERNEURON; METABOLISM; NEUROLOGIC DISEASE; TRANSCRIPTION INITIATION;

ANIMALS; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HIPPOCAMPUS; HUMANS; INTERNEURONS; NERVOUS SYSTEM DISEASES; REGULATORY SEQUENCES, RIBONUCLEIC ACID; RNA, UNTRANSLATED; TRANSCRIPTIONAL ACTIVATION;

EID: 77952287975     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2010.01.015     Document Type: Article

References (73)

1. Wierenga C.J., Becker N., Bonhoeffer T. GABAergic synapses are formed without the involvement of dendritic protrusions. Nat Neurosci 2008, 11(9):1044-1052.
2. Ascoli G.A., Alonso-Nanclares L., Anderson S.A., Barrionuevo G., Benavides-Piccione R., Burkhalter A., et al. Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex. Nat Rev Neurosci 2008, 9(7):557-568.
3. Di Cristo G. Development of cortical GABAergic circuits and its implications for neurodevelopmental disorders. Clin Genet 2007, 72(1):1-8.
4. Hensch T.K. Critical period plasticity in local cortical circuits. Nat Rev Neurosci 2005, 6(11):877-888.
5. Owens D.F., Kriegstein A.R. Developmental neurotransmitters?. Neuron 2002, 36(6):989-991.
6. Pouille F., Scanziani M. Enforcement of temporal fidelity in pyramidal cells by somatic feed-forward inhibition. Science 2001, 293(5532):1159-1163.
7. Swadlow H.A. Fast-spike interneurons and feedforward inhibition in awake sensory neocortex. Cereb Cortex 2003, 13(1):25-32.
8. Wang D.D., Kriegstein A.R. Defining the role of GABA in cortical development. J Physiol 2009, 587(Pt 9):1873-1879.
9. Cossette P., Liu L., Brisebois K., Dong H., Lortie A., Vanasse M., et al. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nat Genet 2002, 31(2):184-189.
10. Noebels J.L. The biology of epilepsy genes. Annu Rev Neurosci 2003, 26:599-625.
11. Cobos I., Calcagnotto M.E., Vilaythong A.J., Thwin M.T., Noebels J.L., Baraban S.C., et al. Mice lacking Dlx1 show subtype-specific loss of interneurons, reduced inhibition and epilepsy. Nat Neurosci 2005, 8(8):1059-1068.
12. Kitamura K., Yanazawa M., Sugiyama N., Miura H., Iizuka-Kogo A., Kusaka M., et al. Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans. Nat Genet 2002, 32(3):359-369.
13. Lewis D.A., Hashimoto T., Volk D.W. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 2005, 6(4):312-324.
14. Addington A.M., Gornick M., Duckworth J., Sporn A., Gogtay N., Bobb A., et al. GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss. Mol Psychiatry 2005, 10(6):581-588.
15. Costa E., Grayson D.R., Guidotti A. Epigenetic downregulation of GABAergic function in schizophrenia: potential for pharmacological intervention?. Mol Interv 2003, 3(4):220-229.
16. Dong E., Agis-Balboa R.C., Simonini M.V., Grayson D.R., Costa E., Guidotti A. Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia. Proc Natl Acad Sci USA 2005, 102(35):12578-12583.
17. DiCicco-Bloom E., Lord C., Zwaigenbaum L., Courchesne E., Dager S.R., Schmitz C., et al. The developmental neurobiology of autism spectrum disorder. J Neurosci 2006, 26(26):6897-6906.
18. Blatt G.J., Fitzgerald C.M., Guptill J.T., Booker A.B., Kemper T.L., Bauman M.L. Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study. J Autism Dev Disord 2001, 31(6):537-543.
19. Casanova M.F., Buxhoeveden D.P., Switala A.E., Roy E. Minicolumnar pathology in autism. Neurology 2002, 58(3):428-432.
20. Ma D.Q., Whitehead P.L., Menold M.M., Martin E.R., Ashley-Koch A.E., Mei H., et al. Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism. Am J Hum Genet 2005, 77(3):377-388.
21. Horike S., Cai S., Miyano M., Cheng J.F., Kohwi-Shigematsu T. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat Genet 2005, 37(1):31-40.
22. Dani V.S., Chang Q., Maffei A., Turrigiano G.G., Jaenisch R., Nelson S.B. Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. Proc Natl Acad Sci USA 2005, 102(35):12560-12565.
23. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999, 23(2):185-188.
24. Chahrour M., Zoghbi H.Y. The story of Rett syndrome: from clinic to neurobiology. Neuron 2007, 56(3):422-437.
25. Nan X., Campoy F.J., Bird A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 1997, 88(4):471-481.
26. Yu W., Gius D., Onyango P., Muldoon-Jacobs K., Karp J., Feinberg A.P., et al. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature 2008, 451(7175):202-206.
27. Mattick J.S. A new paradigm for developmental biology. J Exp Biol 2007, 210(Pt 9):1526-1547.
28. Prasanth K.V., Spector D.L. Eukaryotic regulatory RNAs: an answer to the 'genome complexity' conundrum. Genes Dev 2007, 21(1):11-42.
29. Rapicavoli N.A., Blackshaw S. New meaning in the message: noncoding RNAs and their role in retinal development. Dev Dyn 2009, 238(9):2103-2114.
30. Faghihi M.A., Modarresi F., Khalil A.M., Wood D.E., Sahagan B.G., Morgan T.E., et al. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med 2008, 14(7). 723-30.
31. Korneev S.A., Straub V., Kemenes I., Korneeva E.I., Ott S.R., Benjamin P.R., et al. Timed and targeted differential regulation of nitric oxide synthase (NOS) and anti-NOS genes by reward conditioning leading to long-term memory formation. J Neurosci 2005, 25(5):1188-1192.
32. Millar J.K., James R., Brandon N.J., Thomson P.A. DISC1 and DISC2: discovering and dissecting molecular mechanisms underlying psychiatric illness. Ann Med 2004, 36(5):367-378.
33. Tiedge H., Fremeau R.T., Weinstock P.H., Arancio O., Brosius J. Dendritic location of neural BC1 RNA. Proc Natl Acad Sci USA 1991, 88(6):2093-2097.
34. Wang H., Iacoangeli A., Popp S., Muslimov I.A., Imataka H., Sonenberg N., et al. Dendritic BC1 RNA: functional role in regulation of translation initiation. J Neurosci 2002, 22(23):10232-10241.
35. Lewejohann L., Skryabin B.V., Sachser N., Prehn C., Heiduschka P., Thanos S., et al. Role of a neuronal small non-messenger RNA: behavioural alterations in BC1 RNA-deleted mice. Behav Brain Res 2004, 154(1):273-289.
36. Mus E., Hof P.R., Tiedge H. Dendritic BC200 RNA in aging and in Alzheimer's disease. Proc Natl Acad Sci USA 2007, 104(25):10679-10684.
37. Zalfa F., Adinolfi S., Napoli I., Kuhn-Holsken E., Urlaub H., Achsel T., et al. Fragile X mental retardation protein (FMRP) binds specifically to the brain cytoplasmic RNAs BC1/BC200 via a novel RNA-binding motif. J Biol Chem 2005, 280(39):33403-33410.
38. Zalfa F., Giorgi M., Primerano B., Moro A., Di Penta A., Reis S., et al. The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Cell 2003, 112(3):317-327.
39. Iacoangeli A., Rozhdestvensky T.S., Dolzhanskaya N., Tournier B., Schutt J., Brosius J., et al. On BC1 RNA and the fragile X mental retardation protein. Proc Natl Acad Sci USA 2008, 105(2):734-739.
40. Lin D., Pestova T.V., Hellen C.U., Tiedge H. Translational control by a small RNA: dendritic BC1 RNA targets the eukaryotic initiation factor 4A helicase mechanism. Mol Cell Biol 2008, 28(9):3008-3019.
41. Polesskaya O.O., Haroutunian V., Davis K.L., Hernandez I., Sokolov B.P. Novel putative nonprotein-coding RNA gene from 11q14 displays decreased expression in brains of patients with schizophrenia. J Neurosci Res 2003, 74(1):111-122.
42. Vincent J.B., Petek E., Thevarkunnel S., Kolozsvari D., Cheung J., Patel M., et al. The RAY1/ST7 tumor-suppressor locus on chromosome 7q31 represents a complex multi-transcript system. Genomics 2002, 80(3):283-294.
43. Feng J., Bi C., Clark B.S., Mady R., Shah P., Kohtz J.D. The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator. Genes Dev 2006, 20(11):1470-1484.
44. Bond A.M., VanGompel M.J.W., Sametsky E.A., Clark M.F., Savage J.C., Disterhoft J.D., et al. Balanced gene regulation by an embryonic brain ncRNA is critical for adult hippocampal GABA circuitry. Nat Neurosci 2009, 12:1020-1027.
45. Mutsuddi M., Marshall C.M., Benzow K.A., Koob M.D., Rebay I. The spinocerebellar ataxia 8 noncoding RNA causes neurodegeneration and associates with staufen in Drosophila. Curr Biol 2004, 14(4):302-308.
46. Millar J.K., Wilson-Annan J.C., Anderson S., Christie S., Taylor M.S., Semple C.A., et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 2000, 9(9):1415-1423.
47. Vigneau S., Rohrlich P.S., Brahic M., Bureau J.F. Tmevpg1, a candidate gene for the control of Theiler's virus persistence, could be implicated in the regulation of gamma interferon. J Virol 2003, 77(10):5632-5638.
48. Horike S., Mitsuya K., Meguro M., Kotobuki N., Kashiwagi A., Notsu T., et al. Targeted disruption of the human LIT1 locus defines a putative imprinting control element playing an essential role in Beckwith-Wiedemann syndrome. Hum Mol Genet 2000, 9(14):2075-2083.
49. Mitsuya K., Meguro M., Lee M.P., Katoh M., Schulz T.C., Kugoh H., et al. LIT1, an imprinted antisense RNA in the human KvLQT1 locus identified by screening for differentially expressed transcripts using monochromosomal hybrids. Hum Mol Genet 1999, 8(7):1209-1217.
50. Okutsu T., Kuroiwa Y., Kagitani F., Kai M., Aisaka K., Tsutsumi O., et al. Expression and imprinting status of human PEG8/IGF2AS, a paternally expressed antisense transcript from the IGF2 locus, in Wilms' tumors. J Biochem 2000, 127(3):475-483.
51. Wevrick R., Francke U. An imprinted mouse transcript homologous to the human imprinted in Prader-Willi syndrome (IPW) gene. Hum Mol Genet 1997, 6(2):325-332.
52. Deleault N.R., Lucassen R.W., Supattapone S. RNA molecules stimulate prion protein conversion. Nature 2003, 425(6959):717-720.
53. Supattapone S. Prion protein conversion in vitro. J Mol Med 2004, 82(6):348-356.
54. Sparago A., Cerrato F., Vernucci M., Ferrero G.B., Silengo M.C., Riccio A. Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome. Nat Genet 2004, 36(9):958-960.
55. Jong M.T., Gray T.A., Ji Y., Glenn C.C., Saitoh S., Driscoll D.J., et al. A novel imprinted gene, encoding a RING zinc-finger protein, and overlapping antisense transcript in the Prader-Willi syndrome critical region. Hum Mol Genet 1999, 8(5):783-793.
56. Runte M., Kroisel P.M., Gillessen-Kaesbach G., Varon R., Horn D., Cohen M.Y., et al. SNURF-SNRPN and UBE3A transcript levels in patients with Angelman syndrome. Hum Genet 2004, 114(6):553-561.
57. Lanz R.B., McKenna N.J., Onate S.A., Albrecht U., Wong J., Tsai S.Y., et al. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 1999, 97(1):17-27.
58. Lanz R.B., Razani B., Goldberg A.D., O'Malley B.W. Distinct RNA motifs are important for coactivation of steroid hormone receptors by steroid receptor RNA activator (SRA). Proc Natl Acad Sci USA 2002, 99(25):16081-16086.
59. Shamovsky I., Ivannikov M., Kandel E.S., Gershon D., Nudler E. RNA-mediated response to heat shock in mammalian cells. Nature 2006, 440(7083):556-560.
60. Wang X., Arai S., Song X., Reichart D., Du K., Pascual G., et al. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 2008, 454(7200):126-130.
61. Hashimoto K., Ishida E., Matsumoto S., Shibusawa N., Okada S., Monden T., et al. A liver X receptor (LXR)-beta alternative splicing variant (LXRBSV) acts as an RNA co-activator of LXR-beta. Biochem Biophys Res Commun 2009, 390(4):1260-1265.
62. Nguyen V.T., Kiss T., Michels A.A., Bensaude O. 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes. Nature 2001, 414(6861):322-325.
63. Yang Z., Zhu Q., Luo K., Zhou Q. The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription. Nature 2001, 414(6861):317-322.
64. Yik J.H., Chen R., Nishimura R., Jennings J.L., Link A.J., Zhou Q. Inhibition of P-TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA. Mol Cell 2003, 12(4):971-982.
65. Martianov I., Ramadass A., Serra Barros A., Chow N., Akoulitchev A. Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript. Nature 2007, 445(7128). 666-70.
66. Mariner P.D., Walters R.D., Espinoza C.A., Drullinger L.F., Wagner S.D., Kugel J.F., et al. Human Alu RNA is a modular transacting repressor of mRNA transcription during heat shock. Mol Cell 2008, 29(4):499-509.
67. Rinn J.L., Kertesz M., Wang J.K., Squazzo S.L., Xu X., Brugmann S.A., et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007, 129(7):1311-1323.
68. Zhao J., Sun B.K., Erwin J.A., Song J.J., Lee J.T. Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 2008, 322(5902):750-756.
69. Pandey R.R., Mondal T., Mohammad F., Enroth S., Redrup L., Komorowski J., et al. Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol Cell 2008, 32(2):232-246.
70. Petruk S., Sedkov Y., Riley K.M., Hodgson J., Schweisguth F., Hirose S., et al. Transcription of bxd noncoding RNAs promoted by trithorax represses Ubx in cis by transcriptional interference. Cell 2006, 127(6):1209-1221.
71. Sanchez-Elsner T., Gou D., Kremmer E., Sauer F. Noncoding RNAs of trithorax response elements recruit Drosophila Ash1 to Ultrabithorax. Science 2006, 311(5764):1118-1123.
72. Dinger M.E., Amaral P.P., Mercer T.R., Pang K.C., Bruce S.J., Gardiner B.B., et al. Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation. Genome Res 2008, 18(9):1433-1445.
73. Khalil A.M., Guttman M., Huarte M., Garber M., Raj A., Morales D.R., et al. Many human large intergenic nancoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Nat'l Acad Sci 2009, 106(28):11667-11672.